What does the new OB/GYN guidance say about GLP-1s and pregnancy?

Recent OB/GYN guidance recommends structured preconception counseling for women on GLP-1 medications, rather than a blanket "just stop" approach. It centers on timing discontinuation to the medication's half-life, using proven alternatives like metformin and lifestyle changes once you are actively trying to conceive, and following up with your provider throughout the process. Current data have not shown a clear increase in birth differences from unintended early exposure, but the evidence is still limited and observational, so this is a "plan ahead" conversation, not a "don't worry about it" one.

Always consult your healthcare provider before starting any new supplement, especially during pregnancy, breastfeeding, or while managing a medical condition. This applies to any supplement mentioned in this article, including our 40:1 myo-inositol and D-chiro-inositol blend, which is not intended for use during pregnancy.

Why GLP-1 use in women of reproductive age has changed so fast

Use of GLP-1 medications has risen sharply among women of childbearing age over the past several years, largely for weight and metabolic health management. Clinical guidance has struggled to keep pace with that growth. A 2025 narrative review in Annals of Medicine and Surgery notes that GLP-1 therapy may aid preconception metabolic optimization, but the evidence supporting that role remains limited and largely observational.

That gap between how fast prescribing has grown and how slowly formal guidance has developed is exactly why so many women are left piecing together advice from a pharmacist, an endocrinologist, and an OB/GYN who may not be talking to each other.

What the new guidance says about timing and discontinuation

The emerging consensus is not "stop immediately and hope for the best." It's structured planning. Newer reviews recommend timing discontinuation to the specific medication's half-life, so that the drug clears your system well before conception, rather than picking an arbitrary stopping point.

Research published in the American Journal of Obstetrics and Gynecology found that GLP-1 prescription within 24 months of pregnancy was associated with a reduced risk of certain adverse obstetrical outcomes, including gestational diabetes and hypertensive disorders of pregnancy, in women who had discontinued before conceiving. That is a promising signal about the metabolic groundwork these medications can lay, not a green light to continue use once you are trying to conceive.

What we still don't know (and why that matters)

A 2026 systematic review evaluating maternal, fetal, and neonatal outcomes concluded that preconceptional or early-pregnancy exposure to GLP-1-based therapies has not been consistently linked to increased risk across large observational cohorts, though data on continued use throughout pregnancy remain limited. An editorial in Human Reproduction Open reinforces this by pointing to a nationwide Danish cohort study specifically designed to close this evidence gap, since most existing research has focused on discontinuation before pregnancy rather than exposure that continues into it.

In plain terms: the reassurance that exists so far is about inadvertent, early, brief exposure. It is not reassurance about staying on a GLP-1 once you know you are pregnant.

"There are some positive data coming around GLP-1s and fertility, and it would be nice to get clinical trial data across different populations."

— Dr. Jummy Amuwo, Pharm.D., MPH, BCPS, Clinical Pharmacist and Board Certified Pharmacotherapy Specialist

Supporting your body during the preconception transition

Once you and your provider have a discontinuation plan in place, the preconception window is a good time to shift focus toward foundational reproductive support. Myo Chiro 40:1, formulated to support cycle regularity, pairs a clinically studied 40:1 ratio of Myo-Inositol to D-Chiro-Inositol to support healthy hormone signaling, ovarian health, and menstrual cycle regularity.† Many women layer this alongside our clean-label prenatal with 5-MTHF and iron bisglycinate, starting foundational nutrition 3 to 6 months before actively trying to conceive.†

Myo Chiro 40:1 is not for use during pregnancy and requires a provider consultation before use while breastfeeding. It has no interaction with, and does not replace, any GLP-1 medication. Think of it as separate, complementary support for the reproductive system during the preconception phase, not a substitute for anything your prescriber manages.

What to bring to your own preconception appointment

• The exact name, dose, and last-fill date of your GLP-1 medication
• A clear timeline of when you'd like to start trying to conceive
• Any supplements or over-the-counter products you're currently taking
• Questions about alternative metabolic management options for the preconception window

Pink Stork has built its foundation on pairing this kind of preparation with real support. Folate stores also deserve attention once you stop a GLP-1, and if PCOS is part of your story, the research picture there is worth understanding on its own.

"Every stage of the journey toward motherhood deserves preparation, prayer, and good information. Pink Stork was built to walk alongside you as you get your body ready, one honest step at a time."

— Amy Suzanne Upchurch, Founder and CEO of Pink Stork

Pink Stork is woman-founded and woman-led, with every formula third-party tested at ISO 17025-accredited labs and made in cGMP-certified facilities.

Frequently asked questions

Can I get pregnant while taking a GLP-1 medication?

GLP-1 medications are not recommended during pregnancy. Current guidance recommends planning discontinuation before you start actively trying to conceive, in coordination with your prescribing provider.

How long should I wait after stopping a GLP-1 before trying to conceive?

Discontinuation timing depends on the specific medication's half-life. This is a conversation to have directly with your prescriber, since half-lives vary meaningfully between different GLP-1 medications.

What if I find out I'm pregnant while still on a GLP-1?

Contact your provider right away. Available observational data have not shown a clear increase in congenital differences from unintended early exposure, but data remain limited, so prompt follow-up matters.

What replaces a GLP-1 during the preconception window?

Metformin and lifestyle intervention are the more established alternatives once you are actively trying to conceive, since long-term pregnancy safety data for GLP-1 medications is comparatively thin.

Does stopping a GLP-1 affect fertility itself?

Research suggests GLP-1 therapy may support metabolic factors relevant to fertility in some women, particularly those with obesity or PCOS, but this is an active area of study, not a settled answer.

What should I ask my OB/GYN before trying to conceive on or after a GLP-1?

Ask about your specific discontinuation timeline, what metabolic monitoring makes sense during the transition, and what preconception nutrition or supplementation your provider recommends for your history.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement, especially during pregnancy, breastfeeding, or while managing a medical condition. Keep out of reach of children.